<?xml version="1.0" encoding="UTF-8"?>
<ref id="B81">
 <label>81.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Huttner</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Hatz</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>van den Dobbelsteen</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Abbanat</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Hornacek</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Frolich</surname>
    <given-names>R</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic 
   <italic>Escherichia Coli</italic>. in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
  </article-title>. 
  <source>Lancet Infect. Dis</source>. 
  <volume>17</volume>:
  <fpage>528</fpage>â€“
  <lpage>37</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1473-3099(17)30108-1</pub-id>
  <?supplied-pmid 28238601?>
  <pub-id pub-id-type="pmid">28238601</pub-id>
 </mixed-citation>
</ref>
